Literature DB >> 6288561

Toxic effect of human polymorphonuclear leukocytes on Chlamydia trachomatis.

E C Yong, S J Klebanoff, C C Kuo.   

Abstract

The effect of human polymorphonuclear leukocytes (PMNs) on Chlamydia trachomatis was studied. Both trachoma (B/TW-5/OT) and lymphogranuloma venereum (L2/434/Bu) biotypes were rapidly inactivated by exposure to human PMNs. A decrease of 3 to 3.5 logs in viable count was observed after 60 min of incubation at a chlamydia-to-PMN ratio of 1:10. Both chlamydial biotypes were also rapidly inactivated by the cell-free myeloperoxidase-H2O2-halide system. A decrease in infectivity titer of 4 to 5 logs for TW-5 and complete inactivation of 434 were seen after 30 min of incubation. The microbicidal effect was prevented by the deletion of each component of the system or by the addition of the peroxidase inhibitors cyanide or azide. PMNs from myeloperoxidase-deficient patients inactivated chlamydiae normally, whereas PMNs from patients with chronic granulomatous disease, although strongly chlamydicidal, were less effective than normal PMNs in the activation of TW-5 (2-log drop in viable organisms versus a 3 to 3.5-log drop). The chlamydicidal activity of PMNs from patients with chronic granulomatous disease and normal PMNs were comparable against the 434 biotype. These studies suggest that the myeloperoxidase system, or indeed oxygen-dependent antimicrobial systems, are not essential for the chlamydicidal activity of PMNs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288561      PMCID: PMC347550          DOI: 10.1128/iai.37.2.422-426.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  THE ANTILACTOBACILLUS SYSTEM OF SALIVA. ROLE OF SALIVARY PEROXIDASE.

Authors:  S J KLEBANOFF; R G LUEBKE
Journal:  Proc Soc Exp Biol Med       Date:  1965-02

2.  Endogenous peroxidase in the lacrimal gland of the rat and its differentiation against injected catalase and horseradish-peroxidase.

Authors:  V Herzog; F Miller
Journal:  Histochemie       Date:  1972

3.  Peroxidase-mediated antimicrobial activity of rat uterine fluid.

Authors:  S J Klebanoff; D C Smith
Journal:  Gynecol Invest       Date:  1970

4.  A uterine fluid-mediated sperm-inhibitory system.

Authors:  D C Smith; S J Klebanoff
Journal:  Biol Reprod       Date:  1970-10       Impact factor: 4.285

5.  Localization of endogenous peroxidase in rat exorbital lacrimal gland.

Authors:  E Essner
Journal:  J Histochem Cytochem       Date:  1971-04       Impact factor: 2.479

6.  The source of H2O2 for the uterine fluid-mediated sperm-inhibitory system.

Authors:  S J Klebanoff; D C Smith
Journal:  Biol Reprod       Date:  1970-10       Impact factor: 4.285

7.  Lactoperoxidase: identification and isolation from Harderian and lacrimal glands.

Authors:  M Morrison; P Z Allen
Journal:  Science       Date:  1966-06-17       Impact factor: 47.728

8.  Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes.

Authors:  S J Klebanoff
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

9.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  The localization of endogenous peroxidase in the lacrimal gland of the rat during postnatal development. Electron microscope cytochemical and biochemical studies.

Authors:  V Herzog; F Miller
Journal:  J Cell Biol       Date:  1972-06       Impact factor: 10.539

View more
  22 in total

1.  Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Authors:  Claudio Cortes; V P Ferreira; Michael K Pangburn
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection.

Authors:  N Barteneva; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis.

Authors:  S J Rasmussen; L Eckmann; A J Quayle; L Shen; Y X Zhang; D J Anderson; J Fierer; R S Stephens; M F Kagnoff
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

5.  Degradation of Chlamydia trachomatis in human polymorphonuclear leukocytes: an ultrastructural study of peroxidase-positive phagolysosomes.

Authors:  E C Yong; E Y Chi; W J Chen; C C Kuo
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

Review 6.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

7.  Rapid, transient phosphatidylserine externalization induced in host cells by infection with Chlamydia spp.

Authors:  S R Goth; R S Stephens
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

8.  Binding, ingestion, and multiplication of Chlamydia trachomatis (L2 serovar) in human leukocyte cell lines.

Authors:  J A Bard; D Levitt
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Nonoxidative antimicrobial effects of human polymorphonuclear leukocyte granule proteins on Chlamydia spp. in vitro.

Authors:  K B Register; C H Davis; P B Wyrick; W M Shafer; J K Spitznagel
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

Review 10.  Implications for persistent chlamydial infections of phagocyte-microorganism interplay.

Authors:  I Sarov; E Geron; Y Shemer-Avni; E Manor; M Zvillich; D Wallach; E Schmitz; H Holtman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.